Company Profile
Schrodinger Stock Price, News & Catalysts
- Ticker:
- SDGR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
18.63 USD (-0.11%)
Close
Last updated: August 12, 2026
1.12B USD
Market cap
Why the stock is moving
As of Aug 12, 2026, SDGR was little changed and closed at $18.63. No new same-company headline was identified in the current news window.
Company overview
Business overview
Schrödinger is a computational drug-discovery company combining software, physics-based modeling, and internal therapeutics development.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Schrödinger sits at the intersection of software and biotech.
Business Model Characteristics
The company generates value through software contracts, discovery partnerships, and the optionality of its in-house pipeline.
Position Within the Biotechnology Landscape
Schrödinger is one of the clearest hybrid software-biotech names, with valuation tied to both platform adoption and drug data.
Future catalysts
- Schrödinger's catalysts are SGR-1505, partnered pipeline updates, and software revenue that shows the platform is producing both discovery value and recurring income. The company needs proof on both sides of the business.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Schrodinger (SDGR)?
Schrodinger (SDGR) most recently closed at 18.63 USD, a -0.11% move versus the previous session.
What is the market cap of Schrodinger (SDGR)?
Schrodinger currently has a market capitalization of 1.12B USD on BioPharmSignal.
What does Schrodinger do?
Schrödinger is a computational drug-discovery company combining software, physics-based modeling, and internal therapeutics development.
On which exchange is SDGR stock listed?
Schrodinger (SDGR) is associated with NASDAQ, United States, Biopharma.
What is SGR-1505?
Schrödinger's catalysts are SGR-1505, partnered pipeline updates, and software revenue that shows the platform is producing both discovery value and recurring income.
Which conditions is Schrodinger targeting with SGR-1505?
Schrödinger's catalysts are SGR-1505, partnered pipeline updates, and software revenue that shows the platform is producing both discovery value and recurring income.
How does Schrodinger describe recent progress with SGR-1505?
Schrödinger's catalysts are SGR-1505, partnered pipeline updates, and software revenue that shows the platform is producing both discovery value and recurring income.
What is Schr?
Schrödinger is a computational drug-discovery company combining software, physics-based modeling, and internal therapeutics development.